´ÜÀÏ ¼¼Æ÷ ºÐ¼®ÀÇ ±â¼ú ¹ßÀüÀº »õ·Î¿î Áø´Ü ¹× Ä¡·á ±âȸ¸¦ ÃËÁøÇÕ´Ï´Ù.
´ÜÀÏ ¼¼Æ÷ ºÐ¼®Àº ¼¼Æ÷ ³» À¯ÀüüÇÐ, Àü»çüÇÐ, ´Ü¹éüÇÐ, ´ë»çüÇÐ ¹× ±âŸ ¼¼Æ÷ °£ »óÈ£ ÀÛ¿ëÀ» ¿¬±¸ÇÏ¿© ÀÌÁúÀûÀÎ ¼¼Æ÷ Áý´Ü »ùÇÃÀÇ »óŸ¦ Áø´ÜÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¾¾çÀÇ ¹Ì¼¼ ȯ°æÀ» ´õ Àß ÀÌÇØÇÏ°í ´Ù¾çÇÑ À¯ÇüÀÇ Á¾¾ç¿¡ ´ëÇÑ »õ·Î¿î Áö½ÄÀ» ¹ÙÅÁÀ¸·Î ¾à¹°À» °³¹ßÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¹ýÀ» ÅëÇØ ¾òÀº dzºÎÇÑ µ¥ÀÌÅÍ´Â À¯ÀüÀÚ ¹ßÇö°ú º´¸®¸¦ °áÁ¤ÇÏ´Â ´Ù¸¥ ¿äÀο¡ ´ëÇÑ ±íÀº ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
ÀÌ ¹æ¹ýÀº ÀÌ¹Ì Á¸ÀçÇÏ´Â Áø´Ü ¹× ½Å¾à°³¹ß ¹æ¹ýÀ» ¹ßÀü½ÃŰ´Â °ÍÀ̱⠶§¹®¿¡ ÅõÀÚÀÚ¿Í ¿¬±¸±â°üÀÇ °ü½ÉÀ» ¹Þ°í ÀÖÁö¸¸, ±â¼ú Ç÷§ÆûÀÇ ¹ßÀüÀ¸·Î ±Øº¹ÇØ¾ß ÇÒ ±â¼úÀû °úÁ¦¿Í Áß¼Ò±â¾÷ÀÌ Á¦°øÇÒ ¼ö ¾ø´Â ¿£µåÅõ¿£µå ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ±îÁö ¼ºÀåÇÑ ´ëÇü ½ÃÄö½Ì ±â¾÷ÀÇ µ¶°úÁ¡ µî Ä¡¿ÇÑ °æÀï ȯ°æÀÌ Á¸ÀçÇÕ´Ï´Ù.
¸¹Àº ±â¾÷µéÀÌ °Ô³ðÀ̳ª Àü»çü ¼öÁØÀÇ ´ÜÀÏ ¼¼Æ÷ ºÐ¼®À» Çϰí ÀÖÁö¸¸, ÇÁ·ÎÅ׿À¹Í½º³ª ¸ÖƼ¿À¹Í½ºÀÇ ´ÜÀÏ ¼¼Æ÷ ºÐ¼®À» ÇÏ´Â ±â¾÷Àº ¸¹Áö ¾Ê½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀº ¶óÀ̺귯¸® Áغñ ½Ã °íÀ¯ÇÑ ¹ÙÄÚµå ÇÁ·Î¼¼½º¸¦ ÅëÇÑ ´ÜÀÏ ¼¼Æ÷ ºÐ¸®¿Í °°Àº ¹ø°Å·Î¿î °úÁ¤À» ÇÇÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. °ø°£ ¿À¹Í½º ¹× ¶óÀÌºê ¼¿ ½ÃÄö½Ì°ú °°Àº Ãֽйæ¹ýµµ ±âÁ¸ÀÇ ´ÜÀÏ ¼¼Æ÷ ºÐ¼® ÇÁ·Î¼¼½º¸¦ º¸¿ÏÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¹æ¹ýÀÇ °¡Àå Å« °úÁ¦ Áß Çϳª´Â ½ÃÄö½Ì °á°úÀÇ µ¥ÀÌÅÍ ºÐ¼®Àε¥, ÀÌ´Â ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º °æÇèÀÌ ¾ø¾îµµ Á¶ÀÛÇÒ ¼ö Àִ Ŭ¶ó¿ìµå Ç÷§ÆûÀ» ÅëÇØ ÇØ°áÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¹ý¿¡¼´Â ¾ÆÁ÷ ¹àÇôÁöÁö ¾ÊÀº ÁÖÁ¦¿¡ ´ëÇÑ Á¶»çÀÇ ¿©Áö°¡ ¸¹±â ¶§¹®¿¡ ÇâÈÄ 10³â µ¿¾È ÀÌ ¹æ¹ýÀÌ Å©°Ô ¼ºÀåÇÒ °ÍÀ̸ç, ¾Ï»Ó¸¸ ¾Æ´Ï¶ó ´Ù¸¥ ÁúȯÀÇ Áø´Ü °³¼±µµ ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼´Â ÀÌ ºÐ¾ßÀÇ °úÁ¦, ÃËÁø¿äÀÎ, ½Å±â¼ú Ç÷§Æû, ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ¼ºÀå Àü¸ÁÀ» ¿¹ÃøÇÕ´Ï´Ù. ¶ÇÇÑ, ÀÌÇØ°ü°èÀÚ¿Í ½ÃÀå ÁøÀÔÀÚ°¡ Ȱ¿ëÇØ¾ß ÇÒ ÁÖ¸ñÇÒ ¸¸ÇÑ M&A, ÀÚ±Ý Á¶´Þ ¹× ÆÄÆ®³Ê½ÊÀ» ½Äº°Çϰí ÀÌÇØ°ü°èÀÚ »ýŰ迡 ´ëÇÑ °³¿ä¸¦ Á¦°øÇÕ´Ï´Ù.
¸ñÂ÷
Àü·«Àû °úÁ¦
- ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡?The Strategic Imperative 8(TM) : ¼ºÀåÀ» ¸·´Â ¿äÀÎ
- The Strategic Imperative 8(Áß·«)
- ´ÜÀϼ¼Æ÷ ºÐ¼® ¾÷°è¿¡ ´ëÇÑ ÁÖ¿ä Àü·«Àû Çʼö ¿ä°ÇÀÇ ¿µÇâ
- Growth Pipeline Engine(TM)À» °¡¼ÓÇÏ´Â ¼ºÀå ±âȸ
- Á¶»ç ¹æ¹ý
Á¶»ç ¹üÀ§¿Í ¼¼ºÐÈ
¼ºÀå ±âȸ ºÐ¼®
- ¼ºÀå ÃËÁø¿äÀÎ
- ¼ºÀå ¾ïÁ¦¿äÀÎ
¼·Ð
- ´ÜÀϼ¼Æ÷ ºÐ¼® µµÀÔ°ú ±× Çʿ伺
- ´ÜÀϼ¼Æ÷ ½ÃÄö½Ì ÇÁ·Î¼¼½º °³¹ß ŸÀÓ¶óÀÎ
- ´ÜÀϼ¼Æ÷ ºÐ¼®ÀÇ ¿ëµµ
±â¼ú ÇöȲ
- ´ÜÀϼ¼Æ÷ ºÐ¸®
- ´ÜÀϼ¼Æ÷ ºÐ¸® ±â¼ú - »ó¿ëÈµÈ ¼Ö·ç¼Ç
- ´ÜÀϼ¼Æ÷ ¶óÀ̺귯¸® Áغñ
- ´ÜÀϼ¼Æ÷ ¶óÀ̺귯¸® Áغñ - Çõ½Å
- ´ÜÀϼ¼Æ÷ ½ÃÄö½Ì
- ´ÜÀϼ¼Æ÷ ½ÃÄö½Ì Ç÷§Æû
- ´ÜÀϼ¼Æ÷ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º
- ´ÜÀϼ¼Æ÷ ºÐ¼®¿¡¼ »ç¿ëµÇ´Â ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º Åø
´ÜÀϼ¼Æ÷ ºÐ¼®À» °ÈÇÏ´Â ±â¼ú Áö¿ø
- ´ÜÀÏ ¼¼Æ÷ ºÐ¼®¿¡¼ AI¿Í MLÀÇ ¿µÇâ·Â È®´ë
- ´ÜÀÏ ¼¼Æ÷ ºÐ¼® ±â¼úÀ» º¸¿ÏÇϱâ À§ÇØ ÁøÈÇÏ´Â °ø°£ ¿À¹Í½º ±â¼ú
- ´ÜÀÏ ¼¼Æ÷ ºÐ¼®ÀÇ ¹Ì¼¼ À¯Ã¼ ±â¼ú
´ÜÀϼ¼Æ÷ ºÐ¼®ÀÇ ÃÖ±Ù ±â¼úÀû Áøº¸
- ¼¼Æ÷¸¦ ¼Õ»ó½ÃŰÁö ¾Ê°í °ø°£ Á¤º¸¸¦ Á¦°øÇÏ´Â »ì¾ÆÀÖ´Â ¼¼Æ÷ ¿°±â¼¿ ºÐ¼® ¶Ç´Â ½Ã°£Àû ºÐ¼®
- ´ÜÀÏ ¼¼Æ÷ ¹× ±âŸ ±â¼úÀÇ Á¶ÇÕÀ¸·Î Ä¡·áÁ¦ °³¹ßÀ» À§ÇÑ ½ÉÃþÀûÀÎ ÀλçÀÌÆ® Á¦°ø
- ¼¼Æ÷ ȯ°æ°ú ÀÌÁú¼º¿¡ ´ëÇÑ ´õ ³ªÀº ¹¦»ç¸¦ Á¦°øÇÏ´Â 3D °Ô³ð ±â¼ú
- ´ÜÀÏ ¼¼Æ÷ Ž»ö ¿¬±¸ ȯ°æ
- ´ÜÀÏ ¼¼Æ÷ ºÐ¼®¿¡ ´ëÇÑ ´ëÇÐ ¿¬±¸ °³¿ä
´ÜÀϼ¼Æ÷ ºÐ¼® µ¿Çâ°ú ¹ßÀü
- ÃÖ±Ù 5³â°£ Ç÷§Æû °³¹ß °Ç¼ö Áõ°¡ Ãß¼¼
- Á¾¾çÇÐÀ» ³Ñ¾î¼± ´ÜÀÏ ¼¼Æ÷ ºÐ¼®ÀÇ ÀÀ¿ë ºÐ¾ß È®´ë
- »õ·Î¿î ¹ß°ßÀ» ÅëÇÑ Á¤¹Ð ÀÇÇÐ °È¸¦ À§ÇÑ ´ÜÀÏ ¼¼Æ÷ ¹× °ø°£ ºÐ¼® °³¼±
- ÀÌÇØ°ü°èÀÚ »ýŰè
- ´ÜÀÏ ¼¼Æ÷ ºÐ¼® Àü·«Àû ÆÄÆ®³Ê½Ê
- ÀÚ±Ý Á¶´Þ »ýŰè
- ´ÜÀÏ ¼¼Æ÷ ¹× °ø°£ À¯ÀüüÇÐ ºÐ¾ß¿¡¼ M&A¸¦ ÁÖµµÇÏ´Â ÅëÇÕ ¼Ö·ç¼Ç Á¦°ø¾÷üµé
- ´ÜÀÏ ¼¼Æ÷ ºÐ¼®¿¡ ´ëÇÑ Æ¯Çã Ãâ¿ø ¹× º¸Á¶±Ý ²ÙÁØÈ÷ Áõ°¡ Ãß¼¼
- ´ÜÀÏ ¼¼Æ÷ ºÐ¼® ÀÌÇØ°ü°èÀÚ »ýŰè ȯ°æ
¼ºÀå ±âȸ
- ¼ºÀå ±âȸ 1 : ´ÜÀÏ ¼¼Æ÷ ºÐ¸® ¹× ¶óÀ̺귯¸® ÁغñÀÇ ¹ßÀüÀ¸·Î Àü¹ÝÀûÀÎ ¿öÅ©ÇÃ·Î¿ì °³¼±
- ¼ºÀå ±âȸ 2 : Á¤¹Ð Á¾¾çÇÐÀ» ³Ñ¾î ´ÜÀÏ ¼¼Æ÷ ºÐ¼®ÀÇ Àû¿ë °¡´É¼º È®´ë
- ¼ºÀå ±âȸ 3 : ½ÃÄö½Ì µ¥ÀÌÅÍÀÇ ½Å¼ÓÇϰí ÀÇ¹Ì ÀÖ´Â ÅëÂû·ÂÀ» À§ÇÑ ´ÜÀÏ ¼¼Æ÷ µ¥ÀÌÅÍ °úÇÐÀÇ °³¼±
ºÎ·Ï
´ÙÀ½ ´Ü°è
LSH
Technological advancements in single-cell analysis propel new diagnostic and therapeutic opportunities.
Single-cell analysis can diagnose a condition in heterogenous cell population samples by studying genomics, transcriptomics, proteomics, metabolomics, and other cellular interactions in cells. It helps to understand a tumor microenvironment better and develop drugs based on newly uncovered knowledge of various types of tumors. The rich data provided through this method of analysis gives in-depth insight into gene expression and other factors determining a pathological condition.
As this method is an advancement to already existing methods of diagnosis and drug discovery, it is gaining the attention of investors and research institutions, although there are a few challenges in terms of technology (which must be navigated through advancements in technology platforms) and the monopoly of large sequencing companies that have grown to provide end-to-end solutions that cannot be provided by small and mid-sized companies, creating an intensely competitive environment.
Many companies perform single-cell analysis at the genomic and transcriptomic levels; however, only a few do the same in proteomic and multi-omics single-cell resolution. Technology advancements are helping to bypass tedious processes, such as single-cell separation through a unique barcoding process during library preparation. Modern methods, including spatial omics and live-cell sequencing, are also complementing the existing single-cell analysis process. One of the major challenges in this method is the data analysis of sequenced results, which is being tackled through cloud platforms that operate without the need for prior bioinformatics experience. There is significant scope for research on topics that are underexplored in this method of analysis, which ensures good growth of this technique in the next decade and promises improved diagnosis not only for cancer but also for other diseases.
This study identifies the challenges, drivers, new technology platforms, and growth opportunities in this space and foresees a growth outlook. It also provides an overview of the stakeholder ecosystem, identifying notable mergers and acquisitions, funding, and partnerships for stakeholders and market participants to leverage.
Table of Contents
Strategic Imperatives
- Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
- The Strategic Imperative 8™
- The Impact of the Top 3 Strategic Imperatives on the Single-cell Analysis Industry
- Growth Opportunities Fuel the Growth Pipeline Engine™
- Research Methodology
Scope and Segmentation
- Context and Scope of Analysis
- Segmentation
Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
Introduction
- Introduction to Single-cell Analysis and the Need for It
- Single-cell Sequencing Process Development Time Line
- Single-cell Analysis Applications
Technology Snapshot
- Single-cell Isolation
- Single-cell Isolation Technologies-Commercialized Solutions
- Single-cell Library Preparation
- Single-cell Library Preparation-Innovation
- Single-cell Sequencing
- Single-cell Sequencing Platforms
- Single-cell Bioinformatics
- Bioinformatics Tools Used in Single-cell Analysis
Technology Enablers Bolstering Single-cell Analysis
- Growing Influence of AI and ML in Single-cell Analysis
- Spatial Omics Technologies Evolving to Compliment Single-cell Analysis Technology
- Microfluidic Technologies in Single-cell Analysis
Recent Technological Advancements in Single-cell Analysis
- Live-cell Sequencing or Temporal Analysis Providing Spatial Information Without Damaging Cells
- A Combination of Single-cell and Other Technologies Providing Deeper Insights for Therapy Development
- 3D Genome Technologies Offering a Better Depiction of the Cell Environment and Its Heterogeneity
- Single-cell Exploratory Research Landscape
- Snapshot of University Research in Single-cell Analysis
Trends and Developments in Single-cell Analysis
- Increasing Number of Platform Developments in the Last 5 Years
- Applications of Single-cell Analysis to Expand Beyond Oncology
- Improved Single-cell and Spatial Analysis to Strengthen Precision Medicine Through New Discoveries
- Stakeholder Ecosystem
- Single-cell Analysis Strategic Partnerships
- Funding Ecosystem
- Integrated Solution Providers Dominating M&As in Single-cell and Spatial Genomics
- Steadily Increasing Patent Filings and Grants for Single-cell Analysis
- Landscape of the Single-cell Analysis Stakeholder Ecosystem
Growth Opportunity Universe
- Growth Opportunity 1: Advances in Single-cell Isolation and Library Preparation Improving Overall Workflow
- Growth Opportunity 2: Widening Applicability of Single-cell Analysis Beyond Precision Oncology
- Growth Opportunity 3: Improvement in Single-cell Data Science for Rapid and Meaningful Insights of Sequenced Data
Appendix
- Technology Readiness Levels (TRL): Explanation
Next Steps
- Your Next Steps
- Why Frost, Why Now?
- Legal Disclaimer